Johnson & Johnson to Acquire Atraverse Medical to Expand Cardiac Care Portfolio
Johnson & Johnson has entered into a definitive agreement to acquire Atraverse Medical, a medical device innovator focused on left-heart access technologies. The move...
New Hope for MOGAD Patients: ENSPRYNG Demonstrates Unparalleled 68% Reduction in Disabling Relapses
The Phase III METEOROID study, revealed ENSPRYNG (satralizumab) showing reduction in the risk of relapses by 68% in patients compared to placebo,according to...
India Expands COVID-19 Vaccine Portfolio with New Approvals Including Omicron JN.1 Variant Shot
India’s COVID-19 vaccination landscape continues to evolve, with the Central Drugs Standard Control Organization (CDSCO) releasing an updated list of approved vaccines as of...
Merck Launches Industry-First Bio-Based Solvent Portfolio for (HPLC)
In a significant step toward greener laboratory practices, Merck Group has launched the industry’s first bio-based solvent portfolio designed specifically for high-performance liquid chromatography...
Eli Lilly Expands Oncology Pipeline with Kelonia Buyout, Targets Next-Gen CAR-T Therapy
In a strategic move set to reshape the future of cancer treatment, Eli Lilly and Company has announced its acquisition of Kelonia Therapeutics in...
